
北美给药系统市场至 2027 年 - 按给药途径(经粘膜、口服、注射、局部、植入和眼部)进行区域分析和预测;分销渠道(医院药房、零售药房、网上药房);和申请(家庭护理机构、医院和诊所等)以及国家/地区
No. of Pages: 249 | Report Code: TIPRE00005752 | Category: Life Sciences
No. of Pages: 249 | Report Code: TIPRE00005752 | Category: Life Sciences
北美人体给药系统市场预计将从 2018 年的 572,453.0 百万美元增至 2027 年的 1,074,679.7 百万美元。预计该市场将以 7.4% 的复合年增长率增长2019-2027年。
推动市场增长的关键因素是对大众用药、各市场参与者为维持其市场领导地位而开展的广泛研究和开发项目,从而推出新的创新产品以及在该地区建立完善的制药和医疗器械行业。
在过去的几十年里,由于慢性病的患病率不断增加,药物输送装置的研发 (R&D) 在全球范围内不断增加。疾病。药物递送是施用药物化合物以在人体中达到治疗效果的方法或过程。为了治疗这些慢性疾病,正在研究各种给药途径。根据美国疾病控制与预防中心 (CDC) 2019 年的数据,美国近十分之六的人患有至少一种慢性病,十分之四的人患有两种或两种以上慢性病。此外,癌症是北美地区的主要原因之一。此外,美国癌症协会 (ACS) 估计,2018 年大约诊断出 1,735,350 例新癌症病例。靶向药物递送系统(TDDS)是一种以受控方式在预先选定的生物位点递送药物的系统。糖尿病是一种危及生命的慢性疾病,没有专门的治疗方法。所有类型的糖尿病都会导致身体许多部位出现各种并发症,并会增加过早死亡的总体风险。例如,根据国际糖尿病联盟(IDF)的数据,2017年北美糖尿病患者数量约为4600万,预计到2045年将达到6200万。因此,患有一种糖尿病的患者数量不断增加或更多的慢性疾病预计将在未来几年推动药物输送设备市场的增长。
美国药物输送系统市场预计在预测期内将以最高速度增长。该市场的增长主要是由于糖尿病、哮喘等慢性疾病的患病率不断上升,主要参与者推出的产品数量不断增加;以及更多地使用药物输送系统进行疾病管理。美国地区给药系统市场预计将从2018年的3883.5924亿美元增至2027年的7415.2896亿美元。预测期内该地区市场增长率预计为7.6%。
北美药物输送系统–市场细分
按给药途径
北美药物输送系统 –市场细分
按应用
北美药物输送系统 –市场细分
按
分销渠道
按国家/地区
提及的公司
< /span>
Strategic insights for North America Drug Delivery Systems involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
Report Attribute | Details |
---|---|
Market size in 2018 | US$ 572,453.0 Million |
Market Size by 2027 | US$ 1,074,679.7 Million |
Global CAGR (2019 - 2027) | 7.4% |
Historical Data | 2016-2017 |
Forecast period | 2019-2027 |
Segments Covered |
By 给药途径
|
Regions and Countries Covered | 北美
|
Market leaders and key company profiles |
The regional scope of North America Drug Delivery Systems refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The List of Companies - North America Drug Delivery Systems Market
The North America Drug Delivery Systems Market is valued at US$ 572,453.0 Million in 2018, it is projected to reach US$ 1,074,679.7 Million by 2027.
As per our report North America Drug Delivery Systems Market, the market size is valued at US$ 572,453.0 Million in 2018, projecting it to reach US$ 1,074,679.7 Million by 2027. This translates to a CAGR of approximately 7.4% during the forecast period.
The North America Drug Delivery Systems Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Drug Delivery Systems Market report:
The North America Drug Delivery Systems Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Drug Delivery Systems Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Drug Delivery Systems Market value chain can benefit from the information contained in a comprehensive market report.